Details of the Drug

General Information of Drug (ID: DM9FZYT)

Drug Name
Spesolimab
Synonyms BI-655130
Indication
Disease Entry ICD 11 Status REF
Psoriasis vulgaris EA90 Approved [1]
Palmoplantar pustulosis EA90.42 Phase 2 [2]
Plaque psoriasis EA90.0 Phase 2 [2]
Affected Organisms
Humans and other mammals
ATC Code
L04AC22: Spesolimab
L04AC: Interleukin inhibitors
L04A: IMMUNOSUPPRESSANTS
L04: IMMUNOSUPPRESSANTS
L: ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
Cross-matching ID
UNII
5IB2J79MCX
DrugBank ID
DB15626
TTD ID
D0W9YW

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
IL-1 receptor-like 2 (IL1RL2) TTUS18T ILRL2_HUMAN Antagonist [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 FDA Approved Drug Products from FDA Official Website. 2022. Application Number: 761244.
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)